Publications by authors named "Catherine Labbe-Devilliers"

Claim this Profile
V
Visceral fat and clinical outcome in patients receiving first-line chemotherapy with bevacizumab for metastatic colorectal cancer.
Nicolas Cazeneuve, Olivier Bouché, Julie Leger, Christophe Borg, Catherine Labbe-Devilliers

Clin Res Hepatol Gastroenterol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is Glucagon Administration Compatible With FDG PET/MRI?
Bruno Maucherat, Roshanack Movassaghi, Vincent Fleury, Maelle Le Thiec, Delphine Geffroy, Catherine Labbe-Devilliers

Clin Nucl Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Value of Contrast-Enhanced Ultrasound Quantification Criteria for Identifying Patients not Responding to Bevacizumab-Based Therapy for Colorectal Liver Metastases.
François Tranquart, Paul-Armand Dujardin, Olivier Bouché, Claude Marcus, Christophe Borg, Catherine Labbe-Devilliers

Ultraschall Med· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of dynamic contrast-enhanced ultrasound in predicting outcomes of antiangiogenic therapy for solid tumors: the French multicenter support for innovative and expensive techniques study.
Nathalie Lassau, Julia Bonastre, Michèle Kind, Valérie Vilgrain, Joëlle Lacroix, Catherine Labbe-Devilliers

Invest Radiol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study.
Thomas Bachelot, Gilles Romieu, Mario Campone, Véronique Diéras, Claire Cropet, Catherine Labbe-Devilliers

Lancet Oncol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis